RxDoctor Payments Data

Brian Humphreys, MD

Plastic Surgery within the Head & Neck · Lufkin, TXNPI 1326088469

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 95.7% of the total across 58 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 18 manufacturers reported payments, led by Inspire Medical Systems, Inc. at 30.2% of the total.

$2,294in general payments, 2019–2025

Across 58 payments — averaging $39.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Inspire Medical Systems, Inc.$693
  • Acclarent, Inc$351
  • Sanofi$218
  • Stryker$201
  • Sanofi-aventis U.S. LLC$184
  • Regeneron Healthcare Solutions, Inc.$155
  • plus $493 from 12 others

What the payments were for

  • Food & beverage$2,19596%
  • Education$994%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,294 in reported general payments places this provider in the 60th percentile of 50 plastic surgery within the head & neck providers in Texas.

See all plastic surgery within the head & neck providers in Texas

Medicare billing

Part B allowed, 2024
$145,492
Medicare patients
350
Services billed
3,944

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ipratropium Bromide194$5,200
Fluticasone Propionate204$2,578
Levothyroxine Sodium136$1,545
Esomeprazole Magnesium15$1,520
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth11$1,286
Levocetirizine Dihydrochloride75$1,073
Omeprazole54$1,030
Montelukast Sodium57$618
Tobramycin-DexamethasoneTobramycin/Dexamethasone12$430
Clotrimazole26$427
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim102$405
Acetic Acid13$288
Ciprofloxacin Hcl29$251
Azithromycin28$226
Methylprednisolone24$203

Paid to pharmacies, not to this prescriber.

Other plastic surgery within the head & neck in Lufkin

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →